4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Desonide.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Desonide.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Desonide.
Advertisement
Acetaminophen
The risk or severity of adverse effects can be increased when Desonide is combined with Acetaminophen.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desonide.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Desonide.
Advertisement
Aldesleukin
Desonide may decrease the antineoplastic activities of Aldesleukin.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Desonide.
Aloglutamol
The bioavailability of Desonide can be decreased when combined with Aloglutamol.
Advertisement
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Desonide.
Aluminum
The bioavailability of Desonide can be decreased when combined with Aluminium.
Aluminum Hydroxide
The bioavailability of Desonide can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Desonide can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Desonide can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Desonide is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Desonide.
Amiodarone
The serum concentration of Desonide can be increased when it is combined with Amiodarone.
Amphotericin B
Desonide may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Desonide may increase the hypokalemic activities of Amphotericin B.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Desonide is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Desonide.
Apalutamide
The serum concentration of Desonide can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Desonide.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Desonide.
Aprepitant
The serum concentration of Desonide can be increased when it is combined with Aprepitant.
Asian ginseng extract
The risk or severity of adverse effects can be increased when Desonide is combined with Ginseng.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Desonide.
Atazanavir
The serum concentration of Desonide can be increased when it is combined with Atazanavir.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Desonide.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Desonide.
Azosemide
Desonide may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Desonide.
Bazedoxifene
The serum concentration of Desonide can be increased when it is combined with Bazedoxifene.
BCG Vaccine
The risk or severity of adverse effects can be increased when Desonide is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Desonide is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Desonide is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Desonide may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Desonide.
Benzthiazide
Desonide may increase the hypokalemic activities of Benzthiazide.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Desonide.
Bismuth Subcitrate
The bioavailability of Desonide can be decreased when combined with Bismuth Subcitrate.
Bismuth Subnitrate
The bioavailability of Desonide can be decreased when combined with Bismuth subnitrate.
Boceprevir
The serum concentration of Desonide can be increased when it is combined with Boceprevir.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Desonide.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Desonide.
Bumetanide
Desonide may increase the hypokalemic activities of Bumetanide.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Desonide.
Calcium Carbonate
The bioavailability of Desonide can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Desonide can be decreased when combined with Calcium Carbonate.
Capromab Pendetide
Desonide may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Capsaicin
The risk or severity of adverse effects can be increased when Desonide is combined with Capsaicin.
Carbamazepine
The serum concentration of Desonide can be decreased when it is combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Desonide.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Desonide.
Ceritinib
Desonide may increase the hyperglycemic activities of Ceritinib.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Desonide.
Chlorothiazide
Desonide may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Desonide can be increased when it is combined with Chlorotrianisene.
Chlorphenesin
The risk or severity of adverse effects can be increased when Desonide is combined with Chlorphenesin.
Chlorthalidone
Desonide may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Desonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Desonide.
Cinoxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Cinoxacin.
Ciprofloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Ciprofloxacin.
Cisplatin
The risk or severity of adverse effects can be increased when Desonide is combined with Cisplatin.
Clarithromycin
The serum concentration of Desonide can be increased when it is combined with Clarithromycin.
Clodronic Acid
The risk or severity of adverse effects can be increased when Desonide is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Desonide.
Cobicistat
The serum concentration of Desonide can be increased when it is combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Desonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Desonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Desonide.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Desonide.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Desonide.
Cyclopenthiazide
Desonide may increase the hypokalemic activities of Cyclopenthiazide.
Danazol
Desonide may increase the fluid retaining activities of Danazol.
Darunavir
The serum concentration of Desonide can be increased when it is combined with Darunavir.
Deferasirox
The risk or severity of adverse effects can be increased when Desonide is combined with Deferasirox.
Demecarium
The risk or severity of adverse effects can be increased when Desonide is combined with Demecarium.
Dexketoprofen
The risk or severity of adverse effects can be increased when Desonide is combined with Dexketoprofen.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Desonide.
Dienestrol
The serum concentration of Desonide can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Desonide can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Desonide.
Dipivefrin
The risk or severity of adverse effects can be increased when Desonide is combined with Dipivefrin.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Desonide.
Distigmine
The risk or severity of adverse effects can be increased when Desonide is combined with Distigmine.
Donepezil
The risk or severity of adverse effects can be increased when Desonide is combined with Donepezil.
Drospirenone
The risk or severity of adverse effects can be increased when Desonide is combined with Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Desonide.
Echothiophate
The risk or severity of adverse effects can be increased when Desonide is combined with Echothiophate.
Edrophonium
The risk or severity of adverse effects can be increased when Desonide is combined with Edrophonium.
Eicosapentaenoic Acid
The risk or severity of adverse effects can be increased when Desonide is combined with Icosapent.
Enoxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Enoxacin.
Enzalutamide
The serum concentration of Desonide can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Desonide can be increased when it is combined with Equol.
Estradiol
The serum concentration of Desonide can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Desonide can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Desonide can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Desonide can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Desonide can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Desonide can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Desonide can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Desonide can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Desonide.
Ethacrynate
Desonide may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Desonide may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Desonide can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Desonide.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Desonide.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Desonide.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Desonide.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Desonide.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Desonide.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Desonide.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Desonide.
Fish Oils
The risk or severity of adverse effects can be increased when Desonide is combined with Fish oil.
Fleroxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Desonide.
Flumequine
The risk or severity of adverse effects can be increased when Desonide is combined with Flumequine.
Fluoxymesterone
Desonide may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Desonide.
Fosaprepitant
The serum concentration of Desonide can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Desonide can be decreased when it is combined with Fosphenytoin.
Furosemide
Desonide may increase the hypokalemic activities of Furosemide.
Galantamine
The risk or severity of adverse effects can be increased when Desonide is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Desonide is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Desonide is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Desonide is combined with Gemifloxacin.
Genistein
The serum concentration of Desonide can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Desonide is combined with Ginkgo biloba.
Ginseng Preparation
The risk or severity of adverse effects can be increased when Desonide is combined with Ginseng.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Desonide.
Grepafloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Desonide is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Desonide is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desonide.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desonide.
Hydrochlorothiazide
Desonide may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Desonide may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Desonide can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Desonide can be decreased when it is combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Desonide.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Desonide.
Idelalisib
The serum concentration of Desonide can be increased when it is combined with Idelalisib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Desonide.
Indapamide
Desonide may increase the hypokalemic activities of Indapamide.
Indinavir
The serum concentration of Desonide can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Desonide can be increased when it is combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Desonide.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Desonide.
Isoflurophate
The risk or severity of adverse effects can be increased when Desonide is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Desonide.
Itraconazole
The serum concentration of Desonide can be increased when it is combined with Itraconazole.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Desonide.
Ketoconazole
The serum concentration of Desonide can be increased when it is combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desonide.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Desonide.
Korean ginseng preparation
The risk or severity of adverse effects can be increased when Desonide is combined with Ginseng.
KOREAN GINSENG ROOT
The risk or severity of adverse effects can be increased when Desonide is combined with Ginseng.
Korean Ginseng Root Extract
The risk or severity of adverse effects can be increased when Desonide is combined with Ginseng.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Desonide.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Desonide.
Levofloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Desonide is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Desonide.
Lomefloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Lomefloxacin.
Lopinavir
The serum concentration of Desonide can be increased when it is combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Desonide.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Desonide.
Lumacaftor
The serum concentration of Desonide can be decreased when it is combined with Lumacaftor.
Magaldrate
The bioavailability of Desonide can be decreased when combined with Magaldrate.
Magnesium Carbonate
The bioavailability of Desonide can be decreased when combined with Magnesium carbonate.
Magnesium Hydroxide
The bioavailability of Desonide can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Desonide can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Desonide.
Magnesium silicate
The bioavailability of Desonide can be decreased when combined with Magnesium silicate.
Magnesium Trisilicate
The bioavailability of Desonide can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Desonide is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Desonide.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desonide.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Desonide.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Desonide.
Mefloquine
The risk or severity of adverse effects can be increased when Desonide is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Desonide.
Memantine
The risk or severity of adverse effects can be increased when Desonide is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Desonide.
Mesterolone
Desonide may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Desonide can be increased when it is combined with Mestranol.
Methyclothiazide
Desonide may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Desonide.
Methyltestosterone
Desonide may increase the fluid retaining activities of Methyltestosterone.
Metoclopramide
The risk or severity of adverse effects can be increased when Desonide is combined with Metoclopramide.
Metolazone
Desonide may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Desonide can be decreased when used in combination with Mifepristone.
Minaprine
The risk or severity of adverse effects can be increased when Desonide is combined with Minaprine.
Mitotane
The serum concentration of Desonide can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Desonide.
Morniflumate
The risk or severity of adverse effects can be increased when Desonide is combined with Morniflumate.
Moxifloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Moxifloxacin.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Desonide.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Desonide.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Desonide.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Desonide.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Desonide.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Desonide is combined with Nalidixic Acid.
Nandrolone
Desonide may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Desonide may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Desonide.
Nefazodone
The serum concentration of Desonide can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Desonide can be increased when it is combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Desonide is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Desonide.
Nevirapine
The serum concentration of Desonide can be decreased when it is combined with Nevirapine.
Nicorandil
The risk or severity of adverse effects can be increased when Desonide is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Desonide.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Desonide.
Norfloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Desonide is combined with 1,10-Phenanthroline.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Desonide.
Ofloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Ofloxacin.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Desonide.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Desonide.
Oxandrolone
Desonide may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Desonide.
Oxymetholone
Desonide may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Desonide.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Desonide.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Desonide.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Desonide.
Pefloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Pefloxacin.
Pentobarbital
The serum concentration of Desonide can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Desonide can be decreased when it is combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Desonide.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Desonide.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Desonide.
Phenytoin
The serum concentration of Desonide can be decreased when it is combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Desonide is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Desonide.
Piretanide
Desonide may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Desonide.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Desonide.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Desonide.
Polyestradiol Phosphate
The serum concentration of Desonide can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Desonide may increase the hypokalemic activities of Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Desonide is combined with Pomalidomide.
Posaconazole
The serum concentration of Desonide can be increased when it is combined with Posaconazole.
Primidone
The serum concentration of Desonide can be decreased when it is combined with Primidone.
Promestriene
The serum concentration of Desonide can be increased when it is combined with Promestriene.
Pyridostigmine
The risk or severity of adverse effects can be increased when Desonide is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Desonide is combined with Pyridostigmine.
Quinestrol
The serum concentration of Desonide can be increased when it is combined with Quinestrol.
Quinethazone
Desonide may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Desonide is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Desonide is combined with Rabies virus inactivated antigen, A.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Desonide.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Desonide.
Rifabutin
The serum concentration of Desonide can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Desonide can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Desonide can be decreased when it is combined with Rifapentine.
Rivastigmine
The risk or severity of adverse effects can be increased when Desonide is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Desonide.
Rosoxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Desonide is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Desonide is combined with Rubella virus vaccine.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Desonide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Desonide.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Desonide is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Desonide.
Saquinavir
The serum concentration of Desonide can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Desonide can be increased when it is combined with Saquinavir.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Desonide.
Sodium Bicarbonate
The bioavailability of Desonide can be decreased when combined with Sodium bicarbonate.
Sparfloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Desonide can be decreased when it is combined with St. John's Wort.
Stanozolol
Desonide may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desonide.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Desonide.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Desonide.
synthetic conjugated estrogens, A
The serum concentration of Desonide can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Desonide can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Desonide is combined with Tacrine.
Talniflumate
The risk or severity of adverse effects can be increased when Desonide is combined with Talniflumate.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Desonide.
Telithromycin
The serum concentration of Desonide can be increased when it is combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Desonide.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Desonide.
Testosterone
Desonide may increase the fluid retaining activities of Testosterone.
Testosterone Cypionate
The risk or severity of edema formation can be increased when Testosterone cypionate is combined with Desonide.
Testosterone Enanthate
The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Desonide.
Testosterone Propionate
Desonide may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
The risk or severity of fluid retention can be increased when Testosterone undecanoate is combined with Desonide.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Desonide is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Desonide.
Tibolone
The serum concentration of Desonide can be increased when it is combined with Tibolone.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Desonide.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Desonide.
Torsemide
Desonide may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Desonide.
Triamcinolone
The risk or severity of adverse effects can be increased when Desonide is combined with Triamcinolone.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Desonide.
Trichlormethiazide
Desonide may increase the hypokalemic activities of Trichlormethiazide.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Desonide.
Tromethamine
The bioavailability of Desonide can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Desonide is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Desonide is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Desonide is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Desonide is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Tyrothricin
The risk or severity of adverse effects can be increased when Desonide is combined with Tyrothricin.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Desonide.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Desonide is combined with Varicella Zoster Vaccine (Live/Attenuated).
Voriconazole
The serum concentration of Desonide can be increased when it is combined with Voriconazole.
Warfarin
Desonide may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Desonide is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Desonide is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Desonide.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Desonide.
